CT Atlantic AG Announces Appointment of Michael Höcker to CEO
CT Atlantic AG, a biotechnology company focused on cancer treatment by human-derived antibodies, announced the appointment of Michael Höcker to CEO. In addition, Cara Lerner has been appointed to COO.Michael Höcker most recently served as a Global Medical Director at Hoffmann-La Roche Ltd. (Basel). Prior to this he held executive positions of increasing responsibility at AstraZeneca Ltd. including VP Medical for ... more
Generex Provides Positive Update on Generex Oral-lyn Pivotal Phase III Trial
Generex Biotechnology Corporation announced that it has now achieved 75% of the required number of per-protocol completers in its ongoing six month pivotal global Phase III study of Generex Oral-lyn™, the Company’s proprietary buccal insulin spray product. These early results suggest that, should the current trend be maintained through the early 2011 completion date of the treatment phase of all enrolled ... more
Top